News by Tag: Sulphonylureas
Sales of Diabetes Drugs to Witness Robust Growth in Emerging Markets
July 1, 2011
New studies released by IMARC Group suggests that the sales of diabetes drugs are expected to witness robust growth in major emerging markets.
July 1, 2011
New studies released by IMARC Group suggests that the sales of diabetes drugs are expected to witness robust growth in major emerging markets.
DPP-IV Inhibitors to Account for 17% of the Indian Oral Antidiabetics Market by 2015
July 1, 2011
Driven by a rich pipeline and a strong safety-efficacy profile, the market for DPP-IV inhibitors in India is expected to reach more than US$ 163 Million in the next five years.This would represent around 17% of total oral antidiabetics market by 2015
July 1, 2011
Driven by a rich pipeline and a strong safety-efficacy profile, the market for DPP-IV inhibitors in India is expected to reach more than US$ 163 Million in the next five years.This would represent around 17% of total oral antidiabetics market by 2015